Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Cherkizovo poultry farm buildings on fire in Kursk region

1/9/25 GCHE

VTB completes rebranding of Otkritie branches

1/9/25 VTBR

Shareholders of Perm Energy Supply Company approved dividends

1/9/25 PMSB

Shareholders of Zaymer approved dividends

1/9/25 ZAYM

Inter RAO acquired Mezhregionenergoservice

1/9/25 IRAO

PIK may completely withdraw from the project near the Tretyakov Gallery

1/9/25 PIKK

Segezha Group shareholders approved the additional share issue

12/28/24 SGZH

Promomed will continue to produce an analog of Ozempik

12/28/24 PRMD

Magnit shareholders did not approve dividends

12/28/24 MGNT

Sovcombank's nabsovet determined the price of share buyback from dissenters

12/28/24 SVCB